LILLYKUTTY MODOOR: Open Payments
NPI 1013155969 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 47 payments from 8 companies in 2025. Trend: 2023 $1,652 · 2024 $1,198 · 2025 $1,016
Food & beverage: $1,007Education: $9
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $261 |
| Teva Pharmaceuticals USA, Inc. | 10 | $250 |
| ABBVIE INC. | 3 | $158 |
| Alkermes, Inc. | 12 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
Products named: INGREZZA, AUSTEDO XR, VRAYLAR, ARISTADA, CAPLYTA, REXULTI, HETLIOZ, UZEDY.
Industry payments across NC — which companies pay providers there.
